Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
talacotuzumab (JNJ-56022473)
i
Other names:
JNJ-56022473, CSL362, CSL 362AML, CSL-362, JNJ 56022473, JNJ 56022473, JNJ 473
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
CSL Behring, J&J
Drug class:
CD123 inhibitor
Related drugs:
‹
MGD006 (6)
tagraxofusp-erzs (5)
MGD024 (1)
SAR443579 (1)
XmAb14045 (1)
AFM28 (0)
CD123 targeted CAR-NK (0)
IGM-2537 (0)
JD023 (0)
JNJ-63709178 (0)
MP0533 (0)
SAR440234 (0)
APVO436 (0)
MGD006 (6)
tagraxofusp-erzs (5)
MGD024 (1)
SAR443579 (1)
XmAb14045 (1)
AFM28 (0)
CD123 targeted CAR-NK (0)
IGM-2537 (0)
JD023 (0)
JNJ-63709178 (0)
MP0533 (0)
SAR440234 (0)
APVO436 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login